Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Biomerica (BMRA) over the last 16 years, with Q1 2025 value amounting to -$4000.0.

  • Biomerica's Cash from Investing Activities rose 7500.0% to -$4000.0 in Q1 2025 from the same period last year, while for May 2025 it was -$44000.0, marking a year-over-year increase of 6173.91%. This contributed to the annual value of -$37000.0 for FY2025, which is 6782.61% up from last year.
  • As of Q1 2025, Biomerica's Cash from Investing Activities stood at -$4000.0, which was up 7500.0% from -$24000.0 recorded in Q2 2024.
  • Biomerica's Cash from Investing Activities' 5-year high stood at -$4000.0 during Q1 2025, with a 5-year trough of -$100539.0 in Q1 2021.
  • In the last 5 years, Biomerica's Cash from Investing Activities had a median value of -$24000.0 in 2022 and averaged -$35965.4.
  • In the last 5 years, Biomerica's Cash from Investing Activities crashed by 23152.74% in 2021 and then soared by 8124.71% in 2022.
  • Over the past 5 years, Biomerica's Cash from Investing Activities (Quarter) stood at -$49613.0 in 2021, then soared by 51.63% to -$24000.0 in 2022, then skyrocketed by 50.0% to -$12000.0 in 2023, then crashed by 100.0% to -$24000.0 in 2024, then skyrocketed by 83.33% to -$4000.0 in 2025.
  • Its Cash from Investing Activities was -$4000.0 in Q1 2025, compared to -$24000.0 in Q2 2024 and -$16000.0 in Q1 2024.